Guangdong Electric Power A and others set up enterprise service companies with AI business. The enterprise search APP shows that recently, Guangdong Energy Group Enterprise Service Co., Ltd. was established, with the legal representative of Xu Lin and the registered capital of 150 million yuan. Its business scope includes: artificial intelligence basic resources and technology platform; Research and development of intelligent robots; Artificial intelligence industry application system integration services. Enterprise equity penetration shows that the company is jointly held by Guangdong Electric Power A and others. Guangdong Electric Power A and others set up enterprise service companies with AI business. The enterprise search APP shows that recently, Guangdong Energy Group Enterprise Service Co., Ltd. was established, with the legal representative of Xu Lin and the registered capital of 150 million yuan. Its business scope includes: artificial intelligence basic resources and technology platform; Research and development of intelligent robots; Artificial intelligence industry application system integration services. Enterprise equity penetration shows that the company is jointly held by Guangdong Electric Power A and others.
From January to October, the total output of lithium batteries in China increased by 16% year-on-year. According to the Ministry of Industry and Information Technology, China's lithium-ion battery industry continued to grow from January to October 2024. According to the announcement of lithium battery industry norms, enterprise information and industry associations, the total output of lithium batteries in China from January to October was 890GWh, up 16% year-on-year. According to the data of the National Bureau of Statistics, the profit of China's lithium battery manufacturing industry increased by 39.4% from January to October. In the battery sector, the output of energy storage lithium batteries exceeded 200GWh from January to October. The loading capacity of power lithium batteries for new energy vehicles is about 405GWh. From January to October, the total export of lithium batteries in China reached 350.2 billion yuan, down 9.2% year-on-year, and the decline was 3.3 percentage points narrower than that in January-June.The organization looks forward to the semiconductor industry in 2025: the AI replacement tide leads the growth, and the semiconductor ETF(512480) may usher in new development opportunities. On December 13, the semiconductor ETF(512480) closed down by 1.38%, with a turnover of 1.671 billion yuan. The constituent stocks are mixed, and Zhaoyi Innovation leads the rise. In terms of decline, SMIC led the decline. CICC said that after the boom in 2024, it is expected that the inventory of the semiconductor industry will stabilize and the relationship between supply and demand will be more balanced in 2025. With the gradual landing of AI cloud and end demand, domestic semiconductor elements will usher in new development opportunities. In addition, the AI-changing tide has a pulling effect on the downstream demand of the semiconductor design sector, which is expected to accelerate the growth of the semiconductor design sector in 2025 and inject new vitality into the industry.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.
China Merchants Securities: Investment Guidelines of the Central Economic Work Conference for A-shares next year From these four aspects, China Merchants Securities said that the investment guidelines of the Central Economic Work Conference for A-shares next year mainly include the following aspects: 1) From a macro perspective, the support intensity of policies for various economic work is expected to exceed market expectations. Specifically, the fiscal policy orientation is positive, deficit ratio will arrange or keep it above 3%, the issuance scale of ultra-long-term special government bonds will be further expanded, and the scale and investment field of special bonds are expected to be further extended; Monetary policy mentioned "timely lowering the RRR and cutting interest rates", and the goal of liquidity policy changed from balance to loose tendency, which will bring room for valuation improvement of A shares. 2) From the perspective of expanding domestic demand, consumption will become the main line of investment next year: the meeting will continue the deployment of the Politburo meeting in December, and in the order of writing, consumption will still be placed at the top of next year's key tasks. In terms of specific measures, it is planned to boost consumption mainly through two aspects. First, increase the income of residents; The second is to increase consumption scenarios. 3) Focus on scientific and technological innovation to lead the development of new quality productive forces, and grasp two main lines: this meeting focused on "carrying out' artificial intelligence+'action and cultivating future industries". Artificial intelligence has appeared in the draft of the Central Economic Work Conference for three consecutive years. Future industries have also appeared in the draft of the Central Economic Work Conference for two consecutive years. Therefore, it is recommended to focus on artificial intelligence+and future industries. 4) Focus on "comprehensive improvement of' involution' competition": In terms of "involution" competition, photovoltaic industry is the representative in emerging industries. Recently, in addition to self-regulatory measures such as industry association initiatives, the photovoltaic export tax rebate rate has been lowered and industry norms have been updated to further control new production capacity. The policy is further introduced to curb the "involution" competition of photovoltaics. It is recommended to pay attention to photovoltaic, lithium battery and other industries.On the 13th, the 30-year treasury bond futures rose by 0.60%, and the latest main contract positions changed as follows. According to the data of the exchange, as of December 13th, the main contract 30-year treasury bond futures closed at 2503, up or down by +0.60%, with a turnover of 71,900 lots. The position data showed that the top 20 seats were clear, and the difference position was 3,777 lots. The total number of 30-year treasury bond futures contracts was 82,700 lots, an increase of 4,416 lots over the previous day. The first 20 seats in the contract held 78,000 lots, a decrease of 1,313 lots from the previous day. The top 20 seats in the contract held 85,000 short positions, a decrease of 1,049 lots from the previous day. (Sina Futures)Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14